Sep 29, 2024 | Stock Analysis
Viking Therapeutics, a clinical-stage biopharmaceutical company, has garnered significant attention in 2024 due to its promising weight-loss drug candidate, VK2735. This report delves into the company’s recent clinical trial results, market potential, and... Sep 29, 2024 | Stock Analysis
This report delves into the current state of SoFi Technologies Inc. (NASDAQ: SOFI) stock as of September 2024, examining whether it is a good buy based on various financial metrics, market trends, and Wall Street analysts’ perspectives. The analysis incorporates... Sep 29, 2024 | Stock Analysis
This report examines the implications of China’s recent guidance discouraging local companies from purchasing Nvidia’s H20 series microchips, which are pivotal for AI applications. The analysis delves into the potential impact on Nvidia’s market... Sep 29, 2024 | Investment Ideas
This report delves into the recent developments surrounding Changpeng Zhao (CZ), the founder of Binance, who is set to be released from federal custody on September 27, 2024. The report examines the circumstances leading to his imprisonment, the legal ramifications... Sep 29, 2024 | Investment Ideas
This report delves into the recent developments surrounding OpenAI, focusing on Apple’s decision to withdraw from a significant funding round, OpenAI’s projected financial losses for 2024, and the departure of its Chief Technology Officer (CTO), Mira... 
